Genotoxicity and mitochondrial damage in human lymphocytic cells chronically exposed to 3′-azido-2′,3′-dideoxythymidine

This publication has 24 references indexed in Scilit:

• Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis
  Antimicrobial Agents and Chemotherapy, 1994
• Effect of anti-HIV 2′-β-fluoro-2′,3′-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production
  Biochemical Pharmacology, 1994
• Comparison of mitochondrial morphology, mitochondrial DNA content, and cell viability in cultured cells treated with three anti-human immunodeficiency virus dideoxynucleosides
  Antimicrobial Agents and Chemotherapy, 1994
• Preferential incorporation of 3′‐azido‐2′,3′‐dideoxythymidine into telomeric DNA and Z‐DNA—containing regions of chinese hamster ovary cells
  Molecular Carcinogenesis, 1993
• Thymidine and zidovudine metabolism in chronically zidovudine-exposed cells in vitro
  Biochemical Pharmacology, 1991
• The pc12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs
  Biochemical Pharmacology, 1991
• Mitochondrial Myopathy Caused by Long-Term Zidovudine Therapy
  New England Journal of Medicine, 1990
• Incorporation of 3’-Azido-3’-deoxythymidine into Cellular DNA and Its Removal in a Human Leukemic Cell Line
  Cancer Communications, 1990
• Biochemical pharmacology of zidovudine in human T-lymphoblastoid cells (CEM)
  AIDS, 1989
• Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.
  Proceedings of the National Academy of Sciences, 1986